Bronte Capital Management Pty Ltd. — 13F Holdings & Portfolio

CIK 1471085 · latest 13F-HR filed 2026-08-05

Bronte Capital Management Pty Ltd. manages $931.1M in 13F-reported U.S. long-equity assets across 58 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are GOOGL (11.71%), REGN (10.89%), IBKR (8.26%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 15 new positions, exited 10, added to 12, and trimmed 19.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
SUITE 1703, 101 GRAFTON ST
Bondi Junction, C3 2022
Phone
001 61 2 9389 3293
Filing Manager
Bronte Capital Management Pty Ltd.
Bondi Junction, C3
Signatory
Simon Maher
Managing Director
Loading holdings…
AUM

$931.1M

Long-equity book

Holdings

58

Distinct positions

Period

2026-06-30

Filed 2026-08-05

Q/Q Activity

+15 / −10 / ↑12 / ↓19

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • DISNEY WALT CO$16.8M +93.8%
  • AURORA INNOVATION INC$5.4M +56.1%
  • BBB FOODS INC$5.0M +28.8%
  • SOTERA HEALTH CO$2.1M +16.9%
  • GLOBAL E ONLINE LTD$1.3M +20.3%
Show all 12

Top Trims

  • REGENERON PHARMACEUTICALS-$32.1M -24.0%
  • HERBALIFE NUTRITION LTD-$9.6M -69.3%
  • INTERACTIVE BROKERS GROUP-$9.1M -10.5%
  • VANECK ETF TRUST-$4.6M -24.3%
  • CORTEVA INC-$3.4M -8.1%
Show all 19

New Positions

  • BROWN FORMAN CORP$12.4M
  • REVOLUTION MEDICINES INC$3.5M
  • ISHARES TR$3.4M
  • TYLER TECHNOLOGIES INC$2.4M
  • TREACE MED CONCEPTS INC$62.0K
Show all 15

Exited Positions

  • BROWN FORMAN CORP$13.1M
  • ISHARES TR$11.8M
  • PINTEREST INC$7.9M
  • SALLY BEAUTY HLDGS INC$3.1M
  • JAMES RIV GROUP HOLDINGS INC$2.1M
Show all 10
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ALPHABET INC GOOGL 02079K305 $109.1M 11.71% 305,165 SH
2 REGENERON PHARMACEUTICALS REGN 75886F107 $101.4M 10.89% 162,618 SH
3 INTERACTIVE BROKERS GROUP IBKR 45841N107 $76.9M 8.26% 883,526 SH
4 VISA INC-CLASS A SHARES 83601L105 $75.5M 8.10% 219,914 SH
5 BERKSHIRE HATHAWAY INC DEL BRK.B 084670702 $73.0M 7.84% 145,847 SH
6 AMAZON COM INC AMZN 023135106 $62.3M 6.69% 261,433 SH
7 PHILIP MORRIS INTL INC PM 718172109 $54.3M 5.83% 300,176 SH
8 REGENERON PHARMACEUTICALS Call REGN 75886F107 $42.8M 4.59% 68,600 SH
9 CORTEVA INC CTVA 22052L104 $38.7M 4.15% 456,656 SH
10 CAPITAL ONE FINL CORP COF 14040H105 $34.8M 3.74% 173,523 SH
11 DISNEY WALT CO DIS 254687106 $34.7M 3.72% 360,243 SH
12 FIRST CTZNS BANCSHARES INC N FCNCA 31946M103 $29.5M 3.17% 14,179 SH
13 BBB FOODS INC TBBB G0896C103 $22.2M 2.39% 533,151 SH
14 AURORA INNOVATION INC AUR 051774107 $14.9M 1.60% 2,186,821 SH
15 VANECK ETF TRUST GENZ M8216R110 $14.5M 1.55% 191,580 SH
16 SOTERA HEALTH CO SHC 83601L103 $14.1M 1.52% 797,138 SH
17 NEKTAR THERAPEUTICS NKTR 640268306 $13.9M 1.49% 198,434 SH
18 GRAHAM HLDGS CO GHC 384637104 $13.1M 1.40% 11,454 SH
19 ISHARES TR IBB 464287556 $12.5M 1.34% 65,807 SH
20 BROWN FORMAN CORP BF.B 115637209 $12.4M 1.33% 464,313 SH
21 ALNYLAM PHARMACEUTICALS INC ALNY 02043Q107 $10.7M 1.14% 35,384 SH
22 SOCIEDAD QUIMICA Y MINERA DE SQM 833635105 $8.6M 0.92% 116,308 SH
23 GLOBAL E ONLINE LTD GLBE M5216V106 $7.9M 0.85% 227,644 SH
24 NEWMONT CORP NEM 651639106 $6.5M 0.70% 69,494 SH
25 BARRICK MNG CORP B 06849F108 $5.4M 0.58% 146,359 SH
26 LIVERAMP HLDGS INC RAMP 53815P108 $4.8M 0.52% 128,348 SH
27 HERBALIFE NUTRITION LTD HLF G4412G101 $4.3M 0.46% 323,386 SH
28 REVOLUTION MEDICINES INC RVMD 76155X100 $3.5M 0.38% 18,780 SH
29 TURNING PT BRANDS INC TPB 90041L105 $3.5M 0.37% 40,721 SH
30 ISHARES TR IJR 464287804 $3.4M 0.37% 23,004 SH
31 BATH & BODY WORKS INC BBWI 070830104 $3.3M 0.36% 143,800 SH
32 MONDELEZ INTL INC MDLZ 609207105 $3.1M 0.33% 53,234 SH
33 RISKIFIED LTD RSKD M8216R109 $3.0M 0.32% 588,251 SH
34 BROWN FORMAN CORP BF.A 115637100 $2.6M 0.28% 95,365 SH
35 TYLER TECHNOLOGIES INC TYL 902252105 $2.4M 0.26% 8,302 SH
36 VANECK ETF TRUST GENZ 83601L104 $2.4M 0.26% 24,568 SH
37 PAYLOCITY HLDG CORP PCTY 70438V106 $1.9M 0.20% 17,874 SH
38 NICE LTD NICE 653656108 $1.5M 0.16% 16,396 SH
39 UNIVERSAL DISPLAY CORP OLED 91347P105 $889.2K 0.10% 10,269 SH
40 VERISK ANALYTICS INC VRSK 92345Y106 $481.5K 0.05% 2,682 SH
41 ENOVIX CORPORATION ENVX 293594107 $70.1K 0.01% 11,550 SH
42 TREACE MED CONCEPTS INC TMCI 89455T109 $62.0K 0.01% 15,577 SH
43 FATE THERAPEUTICS INC FATE 31189P102 $58.7K 0.01% 21,740 SH
44 AN2 THERAPEUTICS INC ANTX 037326105 $52.7K 0.01% 10,895 SH
45 C4 THERAPEUTICS INC CCCC 12529R107 $48.3K 0.01% 10,349 SH
46 ALX ONCOLOGY HLDGS INC ALXO 00166B105 $37.5K 0.00% 18,095 SH
47 BLEND LABS INC BLND 09352U108 $32.9K 0.00% 19,247 SH
48 PEPGEN INC PEPG 713317105 $32.0K 0.00% 17,776 SH
49 COMMERCE.COM INC CMRC 08975P108 $30.4K 0.00% 10,278 SH
50 PACIFIC BIOSCIENCES CALIF IN PACB 69404D108 $30.0K 0.00% 17,881 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-05 $931.1M 58 0001471085-26-000004
2026-03-31 2026-04-27 $1.01B 54 0001471085-26-000002
2025-12-31 2026-02-03 $1.00B 44 0001471085-26-000001